A recent wave of national awareness and deeply personal stories in the media made the conversation around endometriosis in Malta louder and more urgent. Now, in a breakthrough development, local wellness and pharmaceutical leader Vivian has launched a new oral treatment for women suffering from this chronic and often misunderstood condition.

 The launch of this new treatment was addressed by internationally acclaimed endometriosis specialist, Prof. Jacques Donnez, a renowned Belgian gynaecologist and recently, the recipient of the Endometriosis Foundation of America’s prestigious Harry Reich Award.

Prof. Donnez, who has focused much of his research for the past 40 years on endometriosis, tubal infertility, and ovarian cryopreservation and transplantation, is globally recognised for his pioneering work in minimally invasive gynaecologic surgery and his commitment to advancing endometriosis care.

Endometriosis affects approximately 1 in 10 women of reproductive age, yet access to effective treatment in Malta has remained limited.

Characterised by the growth of tissue similar to the uterine lining outside the womb, endometriosis is associated with chronic pelvic pain, heavy menstrual bleeding, fatigue, and infertility.

Many women have faced years of misdiagnoses and were left with little more than dietary recommendations, painkillers, or hormonal therapies that may not have worked for everyone. Vivian’s introduction of this new treatment marks a significant shift, from simply raising awareness to delivering a clinically proven, targeted treatment.

“Until now, the conversation around endometriosis in Malta has centred on lifestyle changes and symptom management,” says Daniela Magro from Vivian’s Women’s Health Unit. “With this new treatment, we are finally able to offer patients an effective, non-invasive solution that addresses the root hormonal mechanisms of the disease, giving women not just hope, but real relief.”